Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. (CRON) is a global leader in cannabis innovation, operating across medicinal and recreational markets with brands like Peace Naturals and Spinach. This page provides investors and industry observers with centralized access to official press releases, financial updates, and strategic developments.
Track CRON's progress through earnings reports, regulatory milestones, product launches, and partnership announcements. Our curated news collection ensures you stay informed about operational expansions, research breakthroughs, and market positioning in the evolving cannabis sector.
All content is sourced from verified channels to maintain accuracy and compliance with financial disclosure standards. Bookmark this page for efficient monitoring of CRON's performance across North American, European, and Australian markets.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has scheduled its 2025 first quarter earnings conference call for Thursday, May 8, 2025, at 8:30 a.m. ET. The company's senior management will present financial results and take questions from the investment community following prepared remarks.
Interested participants can register for the conference call and webcast through the company's investor relations website at https://ir.thecronosgroup.com/events-presentations. To ensure timely access, participants are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be made available on Cronos' website after the event.
Cronos Group (NASDAQ: CRON) has announced the launch of new cannabis products under its Spinach® brand, introducing three new 1.2g vape products and expanding its SOURZ by Spinach® edible line.
The new vape lineup features:
- Mango Kiwi Haze CBC (Sativa) with 1:10 CBC-to-THC ratio
- Peach Passionfruit Kush CBN (Indica) with 1:10 CBN-to-THC ratio
- Strawberry Watermelon OG CBG (Hybrid) with 1:10 CBG-to-THC ratio
Each vape contains 1,000mg of THC and features winterized, distilled cannabis extract with ceramic heaters and stainless steel components. The SOURZ by Spinach® Fully Blasted lineup includes new 10mg THC gummies enhanced with rare cannabinoids in three flavors: Mango Lime (with CBC), Peach Passionfruit (with CBN), and Strawberry Watermelon (with CBG).
Cronos Group (NASDAQ: CRON) has appointed Anna Shlimak as Chief Financial Officer, effective March 19, 2025. Shlimak, previously serving as Chief Strategy Officer, succeeds James Holm who will remain with the company through April 18, 2025 to ensure a smooth transition.
Shlimak has been a key member of Cronos' leadership team for seven years, where she has led strategic initiatives in cost optimization, revenue growth, and corporate brand building. CEO Mike Gorenstein expressed confidence in Shlimak's ability to drive financial strategy and growth, citing her deep understanding of the business and track record in driving financial performance.
James Holm, departing after two and a half years, will pursue other opportunities after contributing to improving the company's finance functions and building a robust finance team.
Cronos Group (NASDAQ: CRON) (TSX: CRON), a global cannabinoid company, has announced its participation in the upcoming 37th Annual Roth Conference. Mike Gorenstein, who serves as Chairman, President and CEO, will deliver a presentation on Monday, March 17, 2025, at 1:00 PM PT.
Investors and interested parties can access a live webcast of the presentation through the Investors section of Cronos Group's website at ir.thecronosgroup.com/events-presentations.
Cronos Group (NASDAQ: CRON) reported strong financial results for Q4 and full-year 2024, with Q4 net revenue increasing 27% year-over-year to $30.3 million and full-year revenue up 35% to $117.6 million.
Key highlights include:
- Spinach® ended 2024 as the #1 cannabis brand in Canada, with 5.7% market share in flower category
- PEACE NATURALS® achieved #1 position in Israel with 24% market share
- Company maintains strong balance sheet with $859 million in cash
- Q4 2024 gross profit increased to $10.8 million, up from $1.9 million in Q4 2023
- Adjusted EBITDA improved to $(7.2) million in Q4 2024, a $7.6 million improvement year-over-year
The company expanded operations through Cronos GrowCo investment, enhanced cultivation capabilities, and strengthened international presence in Germany and UK markets.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has announced its upcoming 2024 fourth-quarter and full-year earnings conference call, scheduled for Thursday, February 27, 2025, at 8:30 a.m. ET.
The company's senior management team will present financial results and participate in a Q&A session with the investment community.
Interested participants are encouraged to register online at the company's investor relations website and dial in fifteen minutes before the scheduled start time to avoid delays. The webcast will be archived on Cronos' website for later viewing.
Cronos Group (NASDAQ: CRON) reported strong Q3 2024 results with net revenue increasing 38% year-over-year to $34.3 million. The Spinach® brand became the #1 cannabis brand in Canada, leading in edibles with 17.2% market share. The company maintains a robust balance sheet with $862 million in cash and cash equivalents. Cronos completed its investment in Cronos GrowCo, gaining majority board control and consolidating results from July 2024. Despite a gross profit decrease of 9% to $3.6 million, Adjusted Gross Profit increased 170% to $10.7 million, and Adjusted EBITDA improved by 60% to $(6.0) million.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has scheduled its 2024 third quarter earnings conference call for Tuesday, November 12, 2024, at 8:30 a.m. ET. The company's senior management will present financial results and take questions from the investment community. Participants are encouraged to register online and dial in fifteen minutes before the scheduled start time to avoid delays. A webcast replay will be available on the company's website after the call.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces that its brand Spinach® has become the best-selling cannabis brand in Canada, according to HiFyre Retail Analytics for August 2024. Spinach ranks first in both edibles and flower categories. Launched in November 2018, Spinach has quickly gained popularity among adult consumers.
Mike Gorenstein, Chairman, President and CEO of Cronos, states that this success validates their portfolio and innovation capabilities. Jeff Jacobson, Chief Growth Officer, attributes the brand's success to its focus on enhancing the adult consumer experience. Cronos emphasizes its commitment to quality, innovation, and product development, with plans for more innovative offerings under the Spinach® brand.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is expanding its Lord Jones® brand portfolio in Canada with new cannabis product innovations. The company has introduced new cultivars for Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, now available nationwide. Since its Canadian launch in November 2023, Ice Water Hash Fusions Pre-Rolls have become the best-selling hash-infused pre-rolls in the country. As of July 2024, Lord Jones® has also become the third best-selling live resin vape brand in Canada.
New offerings include Sour Blueberry and Snow Lotus x Animal Mints pre-rolls, featuring 35-41% THC content. The Live Resin Vapes, available in all-in-one devices and 510-cartridges, offer 70+% THC with the new Gorilla Z flavor. These products aim to provide premium, potent experiences for adult consumers, reinforcing Cronos' commitment to product innovation in the Canadian cannabis market.
FAQ
What is the current stock price of Cronos Group (CRON)?
What is the market cap of Cronos Group (CRON)?
